Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)‐deficient mice
- 1 July 2003
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (6) , 1127-1134
- https://doi.org/10.1038/sj.bjp.0705354
Abstract
Overproduction of superoxide anions in the vascular wall contributes to endothelial dysfunction in vascular disease. A superoxide‐generating reduced β‐nicotinamide adenine dinucleotide phosphate (NADPH) oxidase has recently been identified as a major source of oxidative radicals in vascular tissues. We studied the effects of a synthetic manganese‐containing superoxide dismutase (SOD) mimetic, M40403, on NADPH oxidase‐dependent superoxide generation and on endothelial dysfunction. In rat aortic smooth muscle cells, NADPH (100 μM) markedly stimulated superoxide production as detected by lucigenin (5 μM)‐enhanced chemiluminescence. M40403 reduced NADPH oxidase‐dependent superoxide production in a concentration‐dependent manner, with IC50 being 31.6 μM. In contrast, native Cu/Zn SOD (up to 300 U ml−1) had no effect. Angiotensin II (100 nM) increased the NADPH oxidase activity by 70%, and treatment with M40403 (10 μM) reduced this increased superoxide to the control level. In aortae from apolipoprotein(E)‐deficient mice (apoE0) with hyperlipidemia and atherosclerosis, superoxide production is largely derived from NADPH oxidase. The attenuation of endothelial nitric oxide vasodilator function parallels the increase in vascular superoxide production at different stages of the disease. Acute incubation of such aortic rings with M40403 significantly suppressed superoxide production and improved endothelium‐dependent vasorelaxation to a level comparable to that in wildtype control mice. In summary, the cell‐permeable SOD mimetic M40403 was found to reverse endothelial dysfunction in apoE0 aorta ex vivo by decreasing NADPH oxidase‐dependent superoxide levels. The advantages of synthetic SOD mimetics over the native Cu/Zn SOD enzyme, such as greater cell permeability and stability, confer significant therapeutic potential in vascular disease. British Journal of Pharmacology (2003) 139, 1127–1134. doi:10.1038/sj.bjp.0705354Keywords
This publication has 38 references indexed in Scilit:
- Upregulation of Vascular NAD(P)H Oxidase Subunit gp91phox and Impairment of the Nitric Oxide Signal Transduction Pathway in HypertensionBiochemical and Biophysical Research Communications, 2001
- Mechanism of Endothelial Dysfunction in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403British Journal of Pharmacology, 2001
- Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by ThrombinPublished by Elsevier ,1999
- Superoxide Anion Production Is Increased in a Model of Genetic HypertensionHypertension, 1999
- p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996
- Vascular Release of Superoxide Radicals Is Enhanced in Hypercholesterolemic RabbitsJournal of Cardiovascular Pharmacology, 1994
- Hypercholesterolemia increases endothelial superoxide anion production.Journal of Clinical Investigation, 1993
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992